Literature DB >> 19619507

Threonine 53 in alpha-synuclein is conserved in long-living non-primate animals.

Knud Larsen1, Claus Hedegaard, Mads Frost Bertelsen, Christian Bendixen.   

Abstract

Alpha-synuclein is the main constituent of Lewy bodies in familial and sporadic cases of Parkinson's disease (PD). Autosomal dominant point mutations, gene duplications or triplications in the alpha-synuclein (SNCA) gene cause hereditary forms of PD. One of the alpha-synuclein point mutations, Ala53Thr, is associated with increased oligomerization toxicity leading to familial early-onset PD in humans. The amino acid in position 53 in alpha-synuclein is an alanine in humans, great apes and Old World primates. However, this amino acid is a threonine in the alpha-synuclein of all other examined species, including New World monkeys. Here, we present DNA sequence analysis of SNCA and the deduced amino acid sequences of alpha-synuclein cloned from various different species, ranging from fish to mammals, which are known for their long-living potential. In all these investigated species the 53Thr is found. We conclude that 53Thr is not a molecular adaptation for long-living animals to minimize the risk of developing PD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19619507     DOI: 10.1016/j.bbrc.2009.07.070

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Synuclein expression in the lizard Anolis carolinensis.

Authors:  Mattia Toni; Carla Cioni; Federica De Angelis; Maria Carmela Bonaccorsi di Patti
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2016-07-08       Impact factor: 1.836

2.  Synuclein Analysis in Adult Xenopus laevis.

Authors:  Maria Carmela Bonaccorsi di Patti; Elisa Angiulli; Arianna Casini; Rosa Vaccaro; Carla Cioni; Mattia Toni
Journal:  Int J Mol Sci       Date:  2022-05-27       Impact factor: 6.208

Review 3.  α-Synuclein nonhuman primate models of Parkinson's disease.

Authors:  David J Marmion; Jeffrey H Kordower
Journal:  J Neural Transm (Vienna)       Date:  2017-04-22       Impact factor: 3.575

4.  Molecular and Biological Compatibility with Host Alpha-Synuclein Influences Fibril Pathogenicity.

Authors:  Kelvin C Luk; Dustin J Covell; Victoria M Kehm; Bin Zhang; Insung Y Song; Matthew D Byrne; Rose M Pitkin; Samantha C Decker; John Q Trojanowski; Virginia M-Y Lee
Journal:  Cell Rep       Date:  2016-09-20       Impact factor: 9.423

Review 5.  α-Synuclein and nonhuman primate models of Parkinson's disease.

Authors:  Scott C Vermilyea; Marina E Emborg
Journal:  J Neurosci Methods       Date:  2015-08-03       Impact factor: 2.390

Review 6.  New Developments in Genetic rat models of Parkinson's Disease.

Authors:  Rose B Creed; Matthew S Goldberg
Journal:  Mov Disord       Date:  2018-02-08       Impact factor: 10.338

Review 7.  Parkinson's disease mouse models in translational research.

Authors:  Paul M A Antony; Nico J Diederich; Rudi Balling
Journal:  Mamm Genome       Date:  2011-05-11       Impact factor: 2.957

8.  Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus.

Authors:  Michael J Devine; Mina Ryten; Petr Vodicka; Alison J Thomson; Tom Burdon; Henry Houlden; Fatima Cavaleri; Masumi Nagano; Nicola J Drummond; Jan-Willem Taanman; Anthony H Schapira; Katrina Gwinn; John Hardy; Patrick A Lewis; Tilo Kunath
Journal:  Nat Commun       Date:  2011-08-23       Impact factor: 14.919

9.  Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression.

Authors:  Mathieu Bourdenx; Sandra Dovero; Michel Engeln; Simone Bido; Matthieu F Bastide; Nathalie Dutheil; Isabel Vollenweider; Laetitia Baud; Camille Piron; Virginie Grouthier; Thomas Boraud; Grégory Porras; Qin Li; Veerle Baekelandt; Dieter Scheller; Anne Michel; Pierre-Olivier Fernagut; François Georges; Grégoire Courtine; Erwan Bezard; Benjamin Dehay
Journal:  Acta Neuropathol Commun       Date:  2015-07-25       Impact factor: 7.801

Review 10.  Fish Synucleins: An Update.

Authors:  Mattia Toni; Carla Cioni
Journal:  Mar Drugs       Date:  2015-10-30       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.